{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T18:31:49Z","timestamp":1792693909818,"version":"4.5.0"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T00:00:00Z","timestamp":1649980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010816","name":"Anhui Provincial Department of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010816","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>This study aimed to investigate the <jats:italic>Aspergillus<\/jats:italic> species distribution, antifungal sensitivities, clinical characteristics, and risk factors of patients with invasive aspergillosis (IA) in a tertiary teaching hospital in Anhui Province.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In the present study, 156 <jats:italic>Aspergillus<\/jats:italic> isolates were collected from patients admitted to a 2,800-bed comprehensive hospital between January 2019 and April 2021. The epidemiology of <jats:italic>Aspergillus<\/jats:italic> species was well-examined, and its antifungal susceptibility was specifically measured by the microbroth dilution method. The risk factors of patients with IA were documented and analyzed intensively. In addition, gene sequencing was employed to determine gene mutations of cytochrome P450 14-\u03b1 sterol demethylase<jats:italic>-Aspergillus<\/jats:italic> (<jats:italic>cyp51A<\/jats:italic>) associated with azole resistance among <jats:italic>Aspergillus fumigatus<\/jats:italic>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The <jats:italic>Aspergillus<\/jats:italic> species distribution was dominated by <jats:italic>A. fumigatus<\/jats:italic> (56.41%), <jats:italic>Aspergillus flavus<\/jats:italic> (20.51%), and <jats:italic>Aspergillus niger<\/jats:italic> (15.38%) locally. In particular, all <jats:italic>Aspergillus<\/jats:italic> species showed very low minimum inhibitory concentrations (MICs, \u2264 0.5 \u03bcg\/ml) for azoles and echinocandins, slightly high MICs (1.66\u20132.91 \u03bcg\/ml) for amphotericin B, and exceptionally high MICs (&amp;gt;64 \u03bcg\/ml) for flucytosine. Azole-resistant rate of <jats:italic>Aspergillus<\/jats:italic> species in this local region reached up to 5.79%. Correlation analyses of multiple antifungals indicate a significant MIC relevance between isavuconazole and voriconazole (Pearson correlation coefficient was 0.81, <jats:italic>P<\/jats:italic> &amp;lt; 0.0001). The clinical risk factors for patients with IA were found primarily to be pulmonary diseases (<jats:italic>P<\/jats:italic> = 0.007) and patients' age (<jats:italic>P<\/jats:italic> &amp;lt; 0.001). Notably, three mutant loci (TR46\/Y121F\/T289A) of the <jats:italic>cyp51A<\/jats:italic> gene were identified in azole-resistant <jats:italic>A. fumigatus<\/jats:italic>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The <jats:italic>Aspergillus<\/jats:italic> species emerged increasingly, of which <jats:italic>A. fumigatus<\/jats:italic> and <jats:italic>A. flavus<\/jats:italic> remained the main pathogens for invasive <jats:italic>Aspergillus<\/jats:italic> infections in the local region. The vast majority of <jats:italic>Aspergillus<\/jats:italic> species exhibited good susceptibility to all the antifungals, except flucytosine. The local occurrence of azole-resistant <jats:italic>Aspergillus<\/jats:italic> species grew gradually and needed monitoring in time. Pulmonary diseases and age were likely considered as highly associated risk factors for IA. To our knowledge, the clinically isolated azole-resistant <jats:italic>A. fumigatus<\/jats:italic> with TR46\/Y121F\/T289A mutations identified here were rarely reported in the area of China.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2022.835092","type":"journal-article","created":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T05:52:12Z","timestamp":1650001932000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":30,"title":["Epidemiology, Drug Susceptibility, and Clinical Risk Factors in Patients With Invasive Aspergillosis"],"prefix":"10.3389","volume":"10","author":[{"given":"Yuerong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longrong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanhong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e301","DOI":"10.1111\/j.1439-0507.2010.01903.x","article-title":"Hospital costs and outcomes among intravenous antifungal therapies for patients with invasive aspergillosis in the United States","volume":"54","author":"Kim","year":"2011","journal-title":"Mycoses."},{"key":"B2","doi-asserted-by":"publisher","first-page":"165rv13","DOI":"10.1126\/scitranslmed.3004404","article-title":"Hidden killers: human fungal infections","volume":"4","author":"Brown","year":"2012","journal-title":"Sci Transl Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nrmicro.2017.90","article-title":"Aspergillus fumigatus morphology and dynamic host interactions","volume":"15","author":"van de Veerdonk","year":"2017","journal-title":"Nat Rev Microbiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"a019786","DOI":"10.1101\/cshperspect.a019786","article-title":"Aspergillus fumigatus and related species","volume":"5","author":"Sugui","year":"2014","journal-title":"Cold Spring Harb Perspect Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3390\/jof3040057","article-title":"Global and multi-national prevalence of fungal diseases-estimate precision","volume":"3","author":"Bongomin","year":"2017","journal-title":"J Fungi."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1378\/chest.121.6.1988","article-title":"The clinical spectrum of pulmonary aspergillosis","volume":"121","author":"Soubani","year":"2002","journal-title":"Chest."},{"key":"B7","first-page":"5075","article-title":"Misdiagnosis of invasive pulmonary aspergillosis: a clinical analysis of 26 immunocompetent patients","volume":"7","author":"Zhang","year":"2014","journal-title":"Int J Clin Exp Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e109","DOI":"10.1038\/emi.2017.97","article-title":"Triazole phenotypes and genotypic characterization of clinical Aspergillus fumigatus isolates in China","volume":"6","author":"Deng","year":"2017","journal-title":"Emerg Microbes Infect."},{"key":"B9","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1093\/jac\/dkr443","article-title":"Isolation of multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR\/L98H mutations in the cyp51A gene in India","volume":"67","author":"Chowdhary","year":"2012","journal-title":"J Antimicrob Chemother."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.cmi.2016.04.001","article-title":"Azole-resistant Aspergillus fumigatus in Denmark: a laboratory-based study on resistance mechanisms and genotypes","volume":"22","author":"Jensen","year":"2016","journal-title":"Clin Microbiol Infect."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e00437","DOI":"10.1128\/mBio.00437-19","article-title":"Mutations in hmg1, challenging the paradigm of clinical triazole resistance in Aspergillus fumigatus","volume":"10","author":"Rybak","year":"2019","journal-title":"mBio."},{"key":"B12","doi-asserted-by":"publisher","first-page":"S90","DOI":"10.3109\/13693786.2010.508469","article-title":"Acquired antifungal drug resistance in Aspergillus fumigatus: epidemiology and detection","volume":"49","author":"Howard","year":"2011","journal-title":"Med Mycol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and Update of the Consensus Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis."},{"key":"B14","first-page":"960","article-title":"Guidelines for the diagnostic and treatment of invasive fungal infections in critically ill patients","volume":"46","year":"2007","journal-title":"Chin J Intern Med."},{"key":"B15","first-page":"697","article-title":"Diagnostic criteria and treatment principles for invasive pulmonary fungal infections (Draft)","volume":"45","year":"2006","journal-title":"Chin J Intern Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"499","DOI":"10.2147\/IDR.S148121","article-title":"Performance of VITEK mass spectrometry V3.0 for rapid identification of clinical Aspergillus fumigatus in different culture conditions based on ribosomal proteins","volume":"10","author":"Zhou","year":"2017","journal-title":"Infect Drug Resist."},{"key":"B17","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1139\/b91-026","article-title":"Identification of indigenous and introduced symbioticfungi in ectomycorrhizaeby amplification of nuclear and mitochondrial ribosomal DNA","volume":"69","author":"Gardes M","year":"1991","journal-title":"Can J Bot."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1093\/jac\/dkz121","article-title":"Azole resistance and cyp51A mutation screening in Aspergillus fumigatus in Mexico","volume":"74","author":"Gonzalez-Lara","year":"2019","journal-title":"J Antimicrob Chemother."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1128\/AAC.47.3.1120-1124.2003","article-title":"A point mutation in the 14alpha-sterol demethylase gene cyp51A contributes to itraconazole resistance in Aspergillus fumigatus","volume":"47","author":"Diaz-Guerra","year":"2003","journal-title":"Antimicrob Agents Chemother."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1128\/JCM.39.7.2431-2438.2001","article-title":"Identification of two different 14-alpha sterol demethylase-related genes (cyp51A and cyp51B) in Aspergillus fumigatus and other Aspergillus species","volume":"39","author":"Mellado","year":"2001","journal-title":"J Clin Microbiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"4465","DOI":"10.1128\/AAC.00185-11","article-title":"Azole resistance in Aspergillus fumigatus isolates from the ARTEMIS global surveillance study is primarily due to the TR\/L98H mutation in the cyp51A gene","volume":"55","author":"Lockhart","year":"2011","journal-title":"Antimicrob Agents Chemother."},{"key":"B22","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s11684-017-0601-0","article-title":"Epidemiology of fungal infections in China","volume":"12","author":"Chen","year":"2018","journal-title":"Front Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"680884","DOI":"10.3389\/fmicb.2021.680884","article-title":"A 20-year antifungal susceptibility surveillance (From 1999 to 2019) for Aspergillus spp. and proposed epidemiological cutoff values for Aspergillus fumigatus and Aspergillus flavus: a study in a tertiary hospital in China","volume":"12","author":"Yang","year":"2021","journal-title":"Front Microbiol."},{"key":"B24","first-page":"247","article-title":"Epidemiology of aspergillosis in mainland China","volume":"5","author":"Gao","year":"2010","journal-title":"Chin J Mycol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"4321","DOI":"10.1128\/AAC.00003-15","article-title":"Multiple cyp51A-based mechanisms identified in azole-resistant isolates of Aspergillus fumigatus from China","volume":"59","author":"Liu","year":"2015","journal-title":"Antimicrob Agents Chemother."},{"key":"B26","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s10096-010-1137-2","article-title":"Invasive pulmonary aspergillosis in patients with HBV-related liver failure","volume":"30","author":"Wang","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1128\/JCM.03233-14","article-title":"Identification and susceptibility of Aspergillus section nigri in china: prevalence of species and paradoxical growth in response to echinocandins","volume":"53","author":"Li","year":"2015","journal-title":"J Clin Microbiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"625024","DOI":"10.3389\/fbioe.2020.625024","article-title":"Strain distribution and drug susceptibility of invasive fungal infection in clinical patients with systemic internal diseases","volume":"8","author":"Zeng","year":"2020","journal-title":"Front Bioeng Biotechnol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1111\/j.1440-1843.2012.02150.x","article-title":"Pulmonary fungal infections","volume":"17","author":"Smith","year":"2012","journal-title":"Respirology."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e000155","DOI":"10.1136\/bmjresp-2016-000155","article-title":"Clinical manifestations and outcomes of pulmonary aspergillosis: experience from Pakistan","volume":"3","author":"Iqbal","year":"2016","journal-title":"BMJ Open Respir Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1183\/09031936.00054810","article-title":"Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma","volume":"37","author":"Smith","year":"2011","journal-title":"Eur Respir J."},{"key":"B32","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jcf.2018.11.012","article-title":"Prevalence and diversity of filamentous fungi in the airways of cystic fibrosis patients - a Dutch, multicentre study","volume":"18","author":"Engel","year":"2019","journal-title":"J Cyst Fibros."},{"key":"B33","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1146\/annurev-micro-030117-020345","article-title":"Molecular evolution of antifungal drug resistance","volume":"71","author":"Robbins","year":"2017","journal-title":"Annu Rev Microbiol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"4663","DOI":"10.2147\/IDR.S281288","article-title":"Aspergillus species in lower respiratory tract of hospitalized patients from Shanghai, China: species diversity and emerging azole resistance","volume":"13","author":"Xu","year":"2020","journal-title":"Infect Drug Resist."},{"key":"B35","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/myc.13193","article-title":"Antifungal susceptibility profile and molecular identification of cyp51C mutations in clinical and environmental isolates of Aspergillus flavus from Argentina","volume":"64","author":"Hermida-Alava","year":"2021","journal-title":"Mycoses."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1093\/mmy\/myab031","article-title":"Species distribution and antifungal susceptibility patterns of Aspergillus isolates from clinical specimens and soil samples in Mexico","volume":"59","author":"Trevino-Rangel","year":"2021","journal-title":"Med Mycol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/jac\/49.suppl_1.7","article-title":"Amphotericin B: spectrum and resistance","volume":"49","author":"Ellis","year":"2002","journal-title":"J Antimicrob Chemother."},{"key":"B38","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1093\/jac\/41.6.615","article-title":"In-vitro isolation and antifungal susceptibility of amphotericin B-resistant mutants of Aspergillus fumigatus","volume":"41","author":"Manavathu","year":"1998","journal-title":"J Antimicrob Chemother."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1128\/AAC.02130-13","article-title":"Sphingolipid biosynthetic pathway genes FEN1 and SUR4 modulate amphotericin B resistance","volume":"58","author":"Sharma","year":"2014","journal-title":"Antimicrob Agents Chemother."},{"key":"B40","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/BF01739009","article-title":"Amphotericin B versus amphotericin B plus 5-flucytosine: poor results in the treatment of proven systemic mycoses in neutropenic patients","volume":"22","author":"Verweij","year":"1994","journal-title":"Infection."},{"key":"B41","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1093\/jac\/46.2.171","article-title":"Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions","volume":"46","author":"Vermes","year":"2000","journal-title":"J Antimicrob Chemother."},{"key":"B42","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.cmi.2018.11.027","article-title":"Triazole resistance in Aspergillus fumigatus: recent insights and challenges for patient management","volume":"25","author":"Lestrade","year":"2019","journal-title":"Clin Microbiol and Infect."},{"key":"B43","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/jac\/dkh507","article-title":"Mutations in the cyp51A gene and susceptibility to itraconazole in Aspergillus fumigatus serially isolated from a patient with lung aspergilloma","volume":"55","author":"Chen","year":"2005","journal-title":"J Antimicrob Chemother."},{"key":"B44","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/S0140-6736(15)01159-9","article-title":"Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial","volume":"387","author":"Maertens","year":"2016","journal-title":"Lancet."},{"key":"B45","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1128\/JCM.02478-15","article-title":"First detection of TR34 L98H and TR46 Y121F T289A Cyp51 mutations in Aspergillus fumigatus isolates in the United States","volume":"54","author":"Wiederhold","year":"2016","journal-title":"J Clin Microbiol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.drup.2006.01.001","article-title":"Update on antifungal drug resistance mechanisms of Aspergillus fumigatus","volume":"8","author":"Chamilos","year":"2005","journal-title":"Drug Resist Updat."},{"key":"B47","doi-asserted-by":"publisher","first-page":"S233","DOI":"10.1093\/mmy\/myy075","article-title":"Calcium signaling pathway is involved in non-CYP51 azole resistance in Aspergillus fumigatus","volume":"57","author":"Li","year":"2019","journal-title":"Med Mycol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"4934","DOI":"10.1111\/1462-2920.15274","article-title":"Mechanisms of triazole resistance in Aspergillus fumigatus","volume":"22","author":"Nywening","year":"2020","journal-title":"Environ Microbiol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"5878","DOI":"10.1128\/AAC.01005-16","article-title":"Epidemiology and molecular characterizations of azole resistance in clinical and environmental Aspergillus fumigatus isolates from China","volume":"60","author":"Chen","year":"2016","journal-title":"Antimicrob Agents Chemother."},{"key":"B50","doi-asserted-by":"publisher","first-page":"7148","DOI":"10.1128\/AAC.00887-15","article-title":"Emergence of TR46\/Y121F\/T289A in an Aspergillus fumigatus isolate from a Chinese patient","volume":"59","author":"Chen","year":"2015","journal-title":"Antimicrob Agents Chemother."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.3760\/cma.j.issn.0254-6450.2016.12.025","article-title":"Progress of research on azole resistance in Aspergillus fumigatus","volume":"31","author":"Chen","year":"2016","journal-title":"Chin J Epidemiol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1128\/AAC.01092-06","article-title":"A new Aspergillus fumigatus resistance mechanism conferring in vitro cross-resistance to azole antifungals involves a combination of cyp51A alterations","volume":"51","author":"Mellado","year":"2007","journal-title":"Antimicrob Agents Chemother."},{"key":"B53","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1093\/cid\/civ885","article-title":"Azole resistance in Aspergillus fumigatus: can we retain the clinical use of mold-active antifungal azoles?","volume":"62","author":"Verweij","year":"2016","journal-title":"Clin Infect Dis."},{"key":"B54","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/S1473-3099(09)70265-8","article-title":"Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use?","volume":"9","author":"Verweij","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"B55","doi-asserted-by":"publisher","first-page":"697","DOI":"10.2217\/fmb.14.27","article-title":"Exploring azole antifungal drug resistance in Aspergillus fumigatus with special reference to resistance mechanisms","volume":"9","author":"Chowdhary","year":"2014","journal-title":"Future Microbiol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1177\/1060028014537611","article-title":"Fulminant invasive pulmonary aspergillosis after a near-drowning accident in an immunocompetent patient","volume":"48","author":"Ratermann","year":"2014","journal-title":"Ann Pharmacother."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1170 e1","DOI":"10.1016\/j.cmi.2020.09.042","article-title":"Azole resistance survey on clinical Aspergillus fumigatus isolates in Spain","volume":"27","author":"Escribano","year":"2021","journal-title":"Clin Microbiol Infect."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3201\/eid2106.140717","article-title":"Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus","volume":"21","author":"Van der Linden","year":"2015","journal-title":"Emerg Infect Dis."}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2022.835092\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T05:52:20Z","timestamp":1650001940000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2022.835092\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,15]]},"references-count":58,"alternative-id":["10.3389\/fpubh.2022.835092"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2022.835092","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,15]]},"article-number":"835092"}}